Amneal Pharmaceuticals, Inc. (AMRX) Cash Flow Annual - Discounting Cash Flows
AMRX
Amneal Pharmaceuticals, Inc.
AMRX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
Report Filing: 2026-02-27 2026-02-27 2025-02-28 2024-03-14 2023-03-03 2022-03-01 2021-03-01 2020-03-02 2019-03-01 2018-03-09 2016-12-31 2015-12-31 2014-12-31
Net Income/Starting Line 127.9 72.06 -73.88 -48.72 -254.8 10.62 91.06 -603.6 -201.3 169.3 209.4 169.5 176.9
Cash From Operating Activities 340 340 295.1 345.6 65.1 241.8 379 1.71 250.2 234.2 115.1 104.9 112.3
Depreciation and Amortization 223.6 223.6 236.2 229.4 240.2 233.4 244.1 207.2 137.4 45.94 33.02 25.45 20.34
Deferred Income Tax -23.36 0 0 0 0 0 0 371.7 -9.44 0.742 0.121 0 0
Stock Based Compensation 31.95 31.95 27.77 26.82 31.85 0 20.75 21.68 167.6 0 0 0 0
Other Non-Cash Items 184.4 216.9 109.1 185.3 107.8 131.4 84.75 124.9 149 14.52 3.25 -90.02 -85.01
Changes in Working Capital -204.5 -204.5 -4.07 -47.19 -59.95 -133.6 -61.62 -120.2 7.01 -1.05 -152.2 -122.7 -93.28
Accounts Receivable -120.6 -120.6 -162.2 125.8 -79.07 -16.31 16.79 -133.7 89.08 35.26 -122.5 -44.65 -63.66
Inventory -87.03 -87.03 -130.5 -126.2 -102.4 -49.02 -113.8 -20.39 -42.88 -31.83 -42.59 -78.08 -29.62
Accounts Payable 21.32 21.32 235.1 -94.45 109.6 -43.93 0 -10.26 -55.21 18.11 6.26 0 0
Deferred Revenue -18.23 -18.23 53.48 47.64 11.95 -24.34 35.37 44.1 16.01 -22.58 6.65 0 0
Other Working Capital 0 -0.013 0 0 0 -0 0 0 0 0 0 0 0
Cash From Investing Activities -112.3 -112.3 -63 -69.19 -174.3 -194.2 -317.5 -19.58 -396.4 -98.55 -124.6 -135.6 -121
Investments in Property Plant and Equipment -109.2 -70.06 -60.34 -46.8 -48.8 -49.43 -61.84 -47.18 -97.09 -114.3 -124.6 -117.4 -79.38
Payments for Acquisitions 1.57 0 11.99 0 -84.71 -141.5 -251.4 34.83 -324.6 15.72 0 0 0
Purchases of Securities 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales and Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities -4.64 -42.2 -14.65 -22.39 -40.8 -3.21 -4.35 -7.23 25.34 -3.78 -1.85 -18.24 -41.6
Cash From Financing Activities -31.53 -31.53 -211.8 -212.6 -106.6 -138.1 131.8 -45.83 287.7 -95.02 -19.5 -24.99 48.07
Debt Repayment 26.27 26.27 -185.1 22.65 -38.27 -79.18 143 -29.27 541 286.1 188.6 187 298.5
Common Stock Issued 1.96 1.96 0 0 0 0.853 0 0 0 0 0 0 0
Common Stock Repurchased 0 0 0 0 0 0 -0.863 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 -183 -375.3 -200.6 -258.2 -243
Other Financing Activities -59.76 -59.76 -26.67 -235.2 -68.35 -59.8 -10.32 -16.56 -70.37 -5.85 -7.48 46.19 -7.43
Effect of Forex Changes on Cash -1.12 -1.68 -0.999 0.065 -5.68 0.102 1.04 -2.25 -0.67 -0.242 1.48 -0.707 -3.71
Net Change in Cash 242.5 194.5 19.31 63.88 -221.5 -90.38 194.3 -65.96 140.9 40.38 -27.56 -56.44 35.64
Cash at Beginning of Period 68.39 118.4 99.11 35.23 256.7 347.1 152.8 218.8 77.92 37.55 65.11 117.5 81.89
Cash at End of Period 310.9 312.9 118.4 99.11 35.23 256.7 347.1 152.8 218.8 77.92 37.55 61.09 117.5
Free Cash Flow 236.9 269.9 220.1 276.4 -25.5 194.1 317.2 -95.73 153.1 119.9 -9.55 -12.5 32.87
Operating Cash Flow 340 340 295.1 345.6 65.1 241.8 379 1.71 250.2 234.2 115.1 104.9 112.3
Capital Expenditure -103 -70.06 -74.99 -69.19 -90.59 -47.73 -61.84 -97.43 -97.09 -114.3 -124.6 -117.4 -79.38
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program